JA-Gavin Church Yard - The Aurum Institute

TB sequel: incidence, pathogenesis and risk factors of long-term medical and social sequelae of pulmonary TB–a study protocol

Rachow, A., Ivanova, O., Wallis, R., Charalambous, S., Jani, I., Bhatt, N., Kampmann, B., Sutherland, J., Ntinginya, N.E., Evans, D. and Lönnroth, K., Niemann, S.,Ulrich, E., Schaible, Geldmacher, C....
Algorithm-guided empirical tuberculosis treatment for people with advanced HIV (TB Fast Track): an open-label, cluster-randomised trial.

Grant, A.D., Charalambous, S., Tlali, M., Karat, A.S., Dorman, S.E., Hoffmann, C.J., Johnson, S., Vassall, A., Churchyard, G.J., and Fielding, K.L., 2020. Algorithm-guided empirical tuberculosis treat...
Application of provincial data in mathematical modelling to inform sub-national tuberculosis program decision-making in South Africa.

Hippner, P., Sumner, T., Houben, R.M., Cardenas, V., Vassall, A., Bozzani, F., Mudzengi, D., Mvusi, L., Churchyard, G. and White, R.G., 2019. Application of provincial data in mathematical modelling t...
Declines in lung function after antiretroviral therapy initiation in adults with human immunodeficiency virus and tuberculosis: a potential manifestation of respiratory immune reconstitution inflammatory syndrome.

Auld, S.C., Maenetje, P., Ravimohan, S., Weissman, D., Ncube, I., Mlotshwa, M., Ratsela, N., Chase, W., Vangu, M.D.T., Wallis, R. and Churchyard, G., 2020. Declines in lung function after antiretrovir...
What causes symptoms suggestive of tuberculosis in HIV-positive people with negative initial investigations?.

Hanifa, Y., Toro Silva, S., Karstaedt, A., Sahid, F., Charalambous, S., Chihota, V.N., Churchyard, G.J., von Gottberg, A., McCarthy, K., Nicol, M.P., Ndlovu, N.T., Stevens, W., Fielding, K.L., and Gra...
Building a tuberculosis-free world: The Lancet Commission on tuberculosis.

Reid, M.J., Arinaminpathy, N., Bloom, A., Bloom, B.R., Boehme, C., Chaisson, R., Chin, D.P., Churchyard, G., Cox, H., Ditiu, L. and Dybul, M., 2019. Building a tuberculosis-free world: The Lancet Comm...
A Short Regimen for Rifampin-Resistant Tuberculosis.

Churchyard, G.J., A Short Regimen for Rifampin-Resistant Tuberculosis. N Engl J Med. 2019 Mar 28;380(13):1279-1280....
Patient costs incurred by people living with HIV/AIDS prior to ART initiation in primary healthcare facilities in Gauteng, South Africa.

Pillai, N., Foster, N., Hanifa, Y., Ndlovu, N., Fielding, K., Churchyard, G., Chihota, V., Grant, A.D. and Vassall, A., 2019. Patient costs incurred by people living with HIV/AIDS prior to ART initiat...
Controlling latent TB tuberculosis infection in high-burden countries: A neglected strategy to end TB.

Churchyard, G.J. and Swindells, S., 2019. Controlling latent TB tuberculosis infection in high-burden countries: A neglected strategy to end TB. PLoS medicine, 16(4), p.e1002787....
Lung injury on antiretroviral therapy in adults with human immunodeficiency Virus/Tuberculosis.

Ravimohan, S., Auld, S.C., Maenetje, P., Ratsela, N., Mlotshwa, M., Ncube, I., Smith, J.P., Vangu, M.D.T., Sebe, M., Kossenkov, A. and Weissman, D., Wallis, R.S., Churchyard, G., Kornfeld, H., Bisson,...
Guidance for Studies Evaluating the Accuracy of Sputum-Based Tests to Diagnose Tuberculosis.

Schumacher, S.G., Wells, W.A., Nicol, M.P., Steingart, K.R., Theron, G., Dorman, S.E., Pai, M., Churchyard, G., Scott, L., Stevens, W. and Nabeta, P., 2019. Guidance for Studies Evaluating the Accurac...
HIV testing services in healthcare facilities in South Africa: a missed opportunity.

Mabuto, T., Hansoti, B., Kerrigan, D., Mshweshwe‐Pakela, N., Kubeka, G., Charalambous, S., and Hoffmann, C., 2019. HIV testing services in healthcare facilities in South Africa: a missed opportunity...
Willingness to Take Multidrug-resistant Tuberculosis (MDR-TB) Preventive Therapy Among Adult and Adolescent Household Contacts of MDR-TB Index Cases: An International Multisite Cross-sectional Study.

Suryavanshi, N., Murrill, M., Gupta, A., Hughes, M., Hesseling, A., Kim, S., Naini, L., Jones, L., Smith, B., Gupte, N., Dawson, R., Mave, V., Meshram, S., Mendoza-Ticona, A., Sanchez, J., Kumarasamy,...
A common NLRC4 gene variant associates with inflammation and pulmonary function in human immunodeficiency virus and tuberculosis.

Ravimohan, S., Maenetje, P., Auld, S.C., Ncube, I., Mlotshwa, M., Chase, W., Tiemessen, C.T., Vangu, M.D.T., Wallis, R.S., Churchyard, G., Weissman, D., Kornfeld, H., Bisson, G.P., 2019. A common NLRC...
ACTG 5300/IMPAACT I2003 PHOENIx Feasibility study team. 2020.

Gupta, A., Swindells, S., Kim, S., Hughes, M.D., Naini, L., Wu, X., Dawson, R., Mave, V., Sanchez, J., Mendoza, A. and Gonzales, P., Kumarasamy, N., Comins, K., Conradie, F., Shenje, J., Fontain, S.N....
Effect of Xpert MTB/RIF on clinical outcomes in routine care settings: individual patient data meta-analysis.

Di Tanna, G.L., Khaki, A.R., Theron, G., McCarthy, K., Cox, H., Mupfumi, L., Trajman, A., Zijenah, L.S., Mason, P., Bandason, T., Durovni, B., Hoelscher, M., Clowes, P., Mangu, C., Chanda, D., Pym, A....
Cost-effectiveness of one month of daily isoniazid and rifapentine versus three months of weekly isoniazid and rifapentine for prevention of tuberculosis among people receiving antiretroviral therapy in Uganda. J Int AIDS Society 2020

Ferguson, O., Jo, Y., Pennington, J., Johnson, K., Chaisson, R.E., Churchyard, G. and Dowdy, D., 2020. Cost‐effectiveness of one month of daily isoniazid and rifapentine versus three months of weekl...
Cost-effectiveness of a 12 country-intervention to scale up short course TB preventive therapy among people living with HIV. J Int AIDS Soc 2020

Shin, H., Jo, Y., Chaisson, R.E., Turner, K., Churchyard, G. and Dowdy, D.W., 2020. Cost‐effectiveness of a 12 country‐intervention to scale up short course TB preventive therapy among people livi...
After setbacks, rollout of new TB prevention pills to start in six districts

This article was originally written by Tiyese Jeranji for Spotlight on 14th April 2021. After various delays and setbacks, new, less toxic, short-course tuberculosis (TB) prevention therapy is fi...
Aurum at 11th IAS Conference on HIV science

Aurum experts recently presented at the 11th International Aids Society (IAS) Conference, which brought together thousands of HIV professionals virtually from 18 to 21 July. On the opening day of the...

TB sequel: incidence, pathogenesis and risk factors of long-term medical and social sequelae of pulmonary TB–a study protocol

Algorithm-guided empirical tuberculosis treatment for people with advanced HIV (TB Fast Track): an open-label, cluster-randomised trial.

Application of provincial data in mathematical modelling to inform sub-national tuberculosis program decision-making in South Africa.

Declines in lung function after antiretroviral therapy initiation in adults with human immunodeficiency virus and tuberculosis: a potential manifestation of respiratory immune reconstitution inflammatory syndrome.

What causes symptoms suggestive of tuberculosis in HIV-positive people with negative initial investigations?.

Building a tuberculosis-free world: The Lancet Commission on tuberculosis.

A Short Regimen for Rifampin-Resistant Tuberculosis.

Patient costs incurred by people living with HIV/AIDS prior to ART initiation in primary healthcare facilities in Gauteng, South Africa.

Controlling latent TB tuberculosis infection in high-burden countries: A neglected strategy to end TB.

Lung injury on antiretroviral therapy in adults with human immunodeficiency Virus/Tuberculosis.

Guidance for Studies Evaluating the Accuracy of Sputum-Based Tests to Diagnose Tuberculosis.

HIV testing services in healthcare facilities in South Africa: a missed opportunity.

Willingness to Take Multidrug-resistant Tuberculosis (MDR-TB) Preventive Therapy Among Adult and Adolescent Household Contacts of MDR-TB Index Cases: An International Multisite Cross-sectional Study.

A common NLRC4 gene variant associates with inflammation and pulmonary function in human immunodeficiency virus and tuberculosis.

ACTG 5300/IMPAACT I2003 PHOENIx Feasibility study team. 2020.

Effect of Xpert MTB/RIF on clinical outcomes in routine care settings: individual patient data meta-analysis.

Cost-effectiveness of one month of daily isoniazid and rifapentine versus three months of weekly isoniazid and rifapentine for prevention of tuberculosis among people receiving antiretroviral therapy in Uganda. J Int AIDS Society 2020

Cost-effectiveness of a 12 country-intervention to scale up short course TB preventive therapy among people living with HIV. J Int AIDS Soc 2020

After setbacks, rollout of new TB prevention pills to start in six districts

Aurum at 11th IAS Conference on HIV science

Popular Tags

Most Read

Recent Posts

About Us

What We do

Aurum International

Head Office